Tags: pharmaceutical

Online Presentations (1-9 of 9)

  1. Discovery Park at Purdue University: Engine for Academic and Commercial Growth

    10 Jul 2008 | | Contributor(s):: Charles Buck, Pankaj Sharma

    The Bindley Bioscience Center and Birck Nanotechnology Center at Discovery Park blend life sciences and engineering research to cultivate and support innovative, multi-investigator, interdisciplinary research teams. Discovery Park engages researchers in a broader perspective with applications of...

  2. Micro-fabricated Biosensors for Cardiac Diagnostics

    30 Jul 2008 | | Contributor(s):: V.Ramgopal Rao

    In this talk the current status of an ongoing effort in the Electrical Engineering Department at IIT Bombay on the development of an integrated systems to provide point-of-care diagnostic support for cardiovascular diseases will be presented. The system under development monitors the molecular...

  3. Nanohybrids as Sensors and Superstructures

    30 Jul 2008 | | Contributor(s):: K. George Thomas

    We have recently initiated a detailed research program on the design of nanoparticle conjugates of organic/inorganic molecules which enable the coupling of the intrinsic functionalities of molecular systems (binding, self-assembly, switching etc.) with the size and shape dependent optoelectronic...

  4. Pharmaceutical Manufacturing – Present and Future and What Should be the Role of India?

    10 Jul 2008 | | Contributor(s):: Prabir K. Basu

    Pharmaceutical manufacturing is at a crossroads. There is widespread realization among the regulators and the industry that the current state of high variability and “Quality by Inspection” is no longer adequate. While the industry still largely employs first generation quality management tools,...

  5. Quality by Design and Process Analytical Technology for Pharmaceutical Manufacturing in the 21st Century

    21 Jul 2008 | | Contributor(s):: Stephen R. Byrn

    PAT or Process Analytical Technology is an initiative and guidance from the U.S. FDA to encourage modernization of pharmaceutical manufacturing. In reality, PAT is a subset of the larger concept of Quality by Design which is the implementation of design concepts for pharmaceutical dosage forms...

  6. Self-association of peptides and proteins: Retrospect and prospects

    30 Jul 2008 | | Contributor(s):: R. Nagaraj

    The ability of peptides and proteins to form aggregates was known from the dawn of protein and peptide chemistry! It was often considered a nuisance and attention was directed towards disaggregating them to ensure dissolution particularly in aqueous solution. X-ray crystallography has indicated...

  7. So What do Biologist, Biotechnologists & Pharmaceutical Scientist Want With an AFM/SPM Anyway?

    11 Sep 2008 | | Contributor(s):: Kunal Bose

  8. Transforming Pharmaceutical Manufacturing in the 21st Century – Indiana as a Center for Biopharmaceutical Manufacturing

    21 Jul 2008 | | Contributor(s):: Craig K. Svensson

    The pharmaceutical industry is moving from a model of fully integrated pharmaceutical companies to fully networked pharmaceutical companies. In this latter model, major pharmaceutical companies are increasingly relying on partnerships for critical elements in the drug development process. This...

  9. "Who Owns Truth?" - Biomedical Research in a Health Policy Context

    30 Mar 2009 | | Contributor(s):: Samuel A. Richmond

    This presentation examines a claim made by PhRMA on behalf of pharmaceutical manufacturing companies of America, and the response of the International Committee of Medical Journal Editors (ICMJE) questioning drug company publication policies and practices. Also considered are changes in law...